Search clinical trials for: Abgenix

Total 15 results

Amgen

Completed

Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer

Colorectal Cancer | Metastases
Amgen

Completed

Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer

Colorectal Cancer | Metastases
Amgen

Completed

PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study

Colorectal Cancer
Amgen

Completed

Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer | Lung Cancer
Amgen

Completed

Evaluating Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy

Colorectal Cancer | Metastatic Cancer
Amgen

Completed

Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer

Colorectal Cancer
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Completed

Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery

Lung Cancer

United States, Canada
Amgen

Completed

Evaluating ABX-EGF in Patients With Metastatic ColorectalCarcinoma

Carcinoma | Colorectal Cancer
Amgen

Completed

Safety and Efficacy Study of ABX-EGF in Patients With Renal Cancer, Part 2

Advanced Renal Cell Carcinoma
Amgen

Completed

Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer

Colorectal Cancer
Amgen

Completed

Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors

Solid Tumors | Oncology | Tumors
Amgen

Completed

Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment

Colorectal Cancer | Non-Small Cell Lung Cancer | Prostate Cancer | Solid Tumors | Advanced Renal Cell Carcinoma
Abgenix
Immunex Corporation

Completed

ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body

Prostate Cancer

United States
Abgenix

Completed

A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD

Pulmonary Disease, Chronic Obstructive | Bronchitis, Chronic

United States
Abgenix
Sangstat Medical Corporation

Completed

Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease

Graft Vs Host Disease

United States

3

Subscribe